11 DANSK RESUME 13 INTRODUCTION 15 PATHOGENESIS 16 TREATMENT 18 OBJECTIVES 20 METHODS 21 SEARCHING 21 SELECTION 21 VALIDITY ASSESSMENT 21 DATA ABSTRACTION 22 TRIAL CHARACTERISTICS 22 QUANTITATIVE DATA SYNTHESIS 22 RESULTS 23 NON-ABSORBABLE DISACCHARIDES 23 Lactulose or lactitol versus placebo or no intervention 23 Lactulose or lactitol versus antibiotics 25 Conclusion 26 BENZODIAZEPINE RECEPTOR ANTAGONISTS 27 Description of trials 27 Meta-analyses 28 Conclusion 29 BRANCHED-CHAIN AMINO ACIDS 29 Description of trials 29 Meta-analyses 30 Conclusion 32 DOPAMINERGIC AGONISTS 33 Description of trials 33 Meta-analyses 34 Conclusion 35 LIVER SUPPORT SYSTEMS 36

Qian Sc

Papers

[Oral administration of branched-chain amino acids in the treatment of hepatic disease].